Organization
Windtree Therapeutics
6 clinical trials
Clinical trial
Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.Status: Completed, Estimated PCD: 2018-02-08
Clinical trial
A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage CStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Clinical StudyStatus: Completed, Estimated PCD: 2018-08-14
Clinical trial
A Multicenter, Single-Treatment Study to Assess the Safety and Tolerability of Lyophilized Lucinactant in Adults With COVID-19 Associated Acute Lung InjuryStatus: Completed, Estimated PCD: 2022-02-20
Clinical trial
A Multinational, Multicenter, Masked, Randomized, Controlled Study to Assess the Safety and Efficacy of Lucinactant for Inhalation Versus nCPAP Alone in Preterm Neonates 26 to 32 Weeks Gestational Age With RDSStatus: Terminated, Estimated PCD: 2021-01-31
Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study on the Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC)Status: Active (not recruiting), Estimated PCD: 2024-03-30